Filing Details

Accession Number:
0001179110-12-014058
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-14 18:05:25
Reporting Period:
2012-09-12
Filing Date:
2012-09-14
Accepted Time:
2012-09-14 17:05:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203301 W Myron Wentz 3838 West Parkway Blvd
Salt Lake City UT 84120
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-12 7,000 $46.86 7,372,040 No 4 S Indirect Shares owned of record by Gull Holdings
Common Stock Acquisiton 2012-09-14 95,204 $26.06 7,467,244 No 4 M Indirect Shares owned of record by Gull Holdings
Common Stock Disposition 2012-09-14 95,204 $46.29 7,372,040 No 4 S Indirect Shares owned of record by Gull Holdings
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Shares owned of record by Gull Holdings
No 4 M Indirect Shares owned of record by Gull Holdings
No 4 S Indirect Shares owned of record by Gull Holdings
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2012-09-14 219,629 $0.00 219,629 $26.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
280,371 2009-07-21 2014-01-21 No 4 M Direct
Footnotes
  1. The holder of record of the shares of Common Stock disposed is Gull Holdings, Ltd., an entity owned and controlled by Dr. Myron W. Wentz.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2012.
  3. Average price. Price Range was $46.77 to $46.97.
  4. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.
  5. Average price. Price Range was $46.00 to $47.19.